AP535A - Indoline derivatives, method of preparation and use. - Google Patents

Indoline derivatives, method of preparation and use. Download PDF

Info

Publication number
AP535A
AP535A APAP/P/1994/000706A AP9400706A AP535A AP 535 A AP535 A AP 535A AP 9400706 A AP9400706 A AP 9400706A AP 535 A AP535 A AP 535A
Authority
AP
ARIPO
Prior art keywords
formula
compound
compounds
pharmaceutically acceptable
mixture
Prior art date
Application number
APAP/P/1994/000706A
Other languages
English (en)
Other versions
AP9400706A0 (en
Inventor
Peter Charles North
Malcom Clive Carter
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AP9400706A0 publication Critical patent/AP9400706A0/xx
Application granted granted Critical
Publication of AP535A publication Critical patent/AP535A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
APAP/P/1994/000706A 1993-12-22 1994-12-20 Indoline derivatives, method of preparation and use. AP535A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939326192A GB9326192D0 (en) 1993-12-22 1993-12-22 Chemical compounds

Publications (2)

Publication Number Publication Date
AP9400706A0 AP9400706A0 (en) 1995-01-31
AP535A true AP535A (en) 1996-09-16

Family

ID=10747030

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1994/000706A AP535A (en) 1993-12-22 1994-12-20 Indoline derivatives, method of preparation and use.

Country Status (15)

Country Link
US (1) US5633276A (xx)
EP (1) EP0736028A1 (xx)
JP (1) JPH09507057A (xx)
AP (1) AP535A (xx)
AU (1) AU684877B2 (xx)
CA (1) CA2179402A1 (xx)
CO (1) CO4340623A1 (xx)
GB (1) GB9326192D0 (xx)
IL (1) IL112097A (xx)
IS (1) IS4244A (xx)
MY (1) MY131641A (xx)
SV (1) SV1994000083A (xx)
TW (1) TW291479B (xx)
WO (1) WO1995017405A1 (xx)
ZA (1) ZA9410056B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741799B1 (fr) * 1995-12-04 1998-01-02 Oreal Utilisation de melatonine dans une composition pour traiter les signes cutanes des etats de fatigue
NZ330656A (en) * 1996-03-08 1999-06-29 Takeda Chemical Industries Ltd Tricyclic compounds, their production and use
EP1199304A1 (en) * 1997-03-05 2002-04-24 Takeda Chemical Industries, Ltd. Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
RU2190609C2 (ru) * 1996-12-10 2002-10-10 Бристол-Маерс Сквибб Компани Производные бензодиоксола, бензофурана, дигидробензофурана и бензодиоксана и содержащие их композиции
US5948817A (en) * 1997-03-05 1999-09-07 Bristol-Myers Squibb Company Polycyclic ethyl alkylamide melatonergic agents
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU727654B2 (en) * 1997-06-13 2000-12-21 Yamanouchi Pharmaceutical Co., Ltd. Tricyclic pyrazole derivative
CA2334299A1 (en) * 1998-06-05 1999-12-09 Pierre Dextraze Heterocyclic cis cyclopropane derivatives as melatonergic agents
PT1189900E (pt) 1999-06-30 2004-05-31 Bristol Myers Squibb Co Derivados de aminopirrolidina heterociclicos utilizados como agentes melatonergicos
GB9918965D0 (en) * 1999-08-11 1999-10-13 Cerebrus Ltd Chemical compounds xxi
EP1213290B1 (en) 1999-08-20 2005-04-20 Takeda Pharmaceutical Company Limited Dihydrobenzofuran derivatives, process for the preparation thereof and agents
AU1603401A (en) * 2000-03-17 2001-10-03 Alcon Universal Ltd Pyranoindoles for treating glaucoma
US7012090B1 (en) 2000-03-17 2006-03-14 Alcon, Inc. Pyranoindoles for treating glaucoma
ES2172415B2 (es) 2000-07-28 2003-11-16 Univ Madrid Complutense Tratamiento del glaucoma y la hipertension ocular por medio de un analogo de la melatonina.
CA2431566A1 (en) * 2000-12-11 2002-07-18 Testocreme, Llc Topical testosterone formulations and associated methods
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
US20090048325A1 (en) * 2006-03-20 2009-02-19 Takeda Pharmaceutical Company Limited Prophylactic or Therapeutic Agent for Irritable Bowel Syndrome
CA2671354A1 (en) * 2006-12-08 2008-06-12 Takeda Pharmaceutical Company Limited Tricyclic compound and medical use thereof
ES2331274B1 (es) * 2007-10-25 2010-10-21 Ferrer Internacional, S.A. Compuesto de indolina.
RU2011107443A (ru) * 2008-07-30 2012-09-10 Феррер Интернасионал С.А. (ES) Индаценовые соединения, фармацевтическая композиция и лекарственное средство на их основе, способ их получения и способ лечения или профилактики состояний, связанных с нарушением функционирования систем, регулируемых мелатонином, с их помощью
BR102016024814A2 (pt) 2016-10-24 2018-05-08 Aché Laboratórios Farmacêuticos S.A. composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043752A1 (fr) * 1980-06-26 1982-01-13 SOCIETE DE RECHERCHES INDUSTRIELLES S.O.R.I. Société anonyme dite: Dérivé de pyranno-indole et son procédé de préparation
EP0207605A1 (en) * 1985-05-21 1987-01-07 Pfizer Inc. Hypoglycemic thiazolidinediones

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4738972A (en) * 1985-05-21 1988-04-19 Pfizer Inc. Hypoglycemic thiazolidinediones

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043752A1 (fr) * 1980-06-26 1982-01-13 SOCIETE DE RECHERCHES INDUSTRIELLES S.O.R.I. Société anonyme dite: Dérivé de pyranno-indole et son procédé de préparation
EP0207605A1 (en) * 1985-05-21 1987-01-07 Pfizer Inc. Hypoglycemic thiazolidinediones

Also Published As

Publication number Publication date
IL112097A (en) 1998-06-15
TW291479B (xx) 1996-11-21
IS4244A (is) 1995-06-23
EP0736028A1 (en) 1996-10-09
ZA9410056B (en) 1995-10-18
WO1995017405A1 (en) 1995-06-29
GB9326192D0 (en) 1994-02-23
CO4340623A1 (es) 1996-07-30
JPH09507057A (ja) 1997-07-15
CA2179402A1 (en) 1995-06-29
AU684877B2 (en) 1998-01-08
AP9400706A0 (en) 1995-01-31
SV1994000083A (es) 1995-07-24
IL112097A0 (en) 1995-03-15
US5633276A (en) 1997-05-27
MY131641A (en) 2007-08-30
AU1274395A (en) 1995-07-10

Similar Documents

Publication Publication Date Title
AP535A (en) Indoline derivatives, method of preparation and use.
JP2941309B2 (ja) 化合物
JP5271903B2 (ja) オピオイド受容体系に作用する、4−ヘテロアリール置換された1−アミノシクロヘキサン−1−及びシクロヘキセン−1−誘導体
RU2095360C1 (ru) Производные индола, их оптические изомеры и фармацевтически приемлемые соли
JP3033076B2 (ja) カンナビノイド受容体への親和性を有するインドール誘導体
KR930003759B1 (ko) 인돌 유도체의 제조방법
US5981572A (en) Benzofurans and benzopyrans as chronobiological agents
LU85743A1 (fr) Composes heterocycliques
JPH06199784A (ja) 新規なアリールエチアミン化合物、その製法、及びこれを含有する医薬組成物。
JPS6277383A (ja) 複素環式化合物
JPH10508297A (ja) ニューロキニンアンタゴニストとしての置換アリールピペラジン
JP2000510153A (ja) スピロ―ピペリジン誘導体及び該誘導体の治療薬としての使用
JPH08506823A (ja) アザ環式化合物、該化合物を含む組成物及びタキキニン拮抗剤としての該化合物の使用
JP2000515136A (ja) プロテインチロシンキナーゼ阻害剤としての二環式ヘテロ芳香族化合物
JP2001521925A (ja) Pde4阻害剤におけるカテコールのインダゾールバイオイソステル置換に基づく治療学的に活性な化合物
US7060710B2 (en) Isoxazole pyrazoloindane derivatives as cognition enhancing GABAA α5 subtype ligands
JPH10502336A (ja) ナフタレン誘導体、製造方法および使用
CH667454A5 (fr) Derives d'indoles.
US20030073832A1 (en) Novel aminophenyl ketone derivatives
JP2001504501A (ja) 5−ht▲下1d▼レセプターのリガンドとしての5−シクロインドール化合物
JPH05262766A (ja) ピペリジルメチル−置換クロマン誘導体
JP2941333B2 (ja) インドール誘導体
JP2791069B2 (ja) シクロオクタン神経保護剤
JPH06505698A (ja) 新規化合物
JPH09512034A (ja) 5ht1−様作動薬としてのインドール誘導体